Bad Medicine: The Prescription Drug Industry in the Third World

Valutazione media 3
( su 1 valutazioni fornite da Goodreads )
 
9780804716697: Bad Medicine: The Prescription Drug Industry in the Third World

The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities.
In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups―the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)―all of which were or still are centers of worldwide, heated controversy.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

From Kirkus Reviews:

Silverman, Lydecker, and Lee--who took upon themselves the seemingly Sisyphean task of exposing the abuses of the pharmaceutical industry (Prescriptions for Death: The Drugging of the Third World, 1982, etc.)--now reexamine the situation in the Third World and conclude that a worldwide crisis exists. The present survey, begun in 1987, indicates that most multinational drug companies, under pressure from within and without, have improved the way they label and market their products. But apparently the public hasn't benefited--for, the authors contend, scores of useless and dangerous drugs are now put out by local or domestic firms, small in size but large in political clout. Fraudulent drugs abound, and badly needed ones are unavailable. The authors cite some small success stories- -India's ban on deadly, high-dosage hormones, and a pilot project in Gambia in which drug companies and the government cooperated to set up a drug-distribution system--but they observe that, in most developing nations, drug-regulation agencies are corrupt, weak, and underfunded, and their workers poorly trained. Bribery, the authors note, is a way of life throughout the Third World. They conclude that what's needed is constant surveillance, as well as continuous consultation among consumer advocates, the drug industry, government agencies, and the medical and pharmacy professions, with the World Health Organization leading the way. The scrutiny is close, the research impressive, though the presentation is so detailed that it may overwhelm all but the most concerned reader. Still, a thorough assessment of a perilous situation. -- Copyright ©1992, Kirkus Associates, LP. All rights reserved.

Review:

'Bad Medicine offers a wealth of information which is urgently needed by health policy planners, health professionals, consumers, and the pharmaceutical industry. To my knowledge, this objective and well-documented data, which is thoroughly assessed and interpreted, is available nowhere else. The book shows in detail which companies are promoting their products with honesty and responsibility and which companies are still trying to treat doctors and patients. Furthermore, it holds the reader's attention from first to last.' Dr. Klaus von Grebmer, Giba-Geigy, Switzerland

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Milton Silverman; Mia Lydecker; Philip R. Lee
Editore: Stanford University Press (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Rilegato Prima edizione Quantità: 1
Da
Irish Booksellers
(Rumford, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, 1992. Hardcover. Condizione libro: New. book. Codice libro della libreria M0804716692

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 40,22
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

2.

Silverman, Milton
Editore: Stanford Univ Pr (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Quantità: 10
Da
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Stanford Univ Pr, 1992. HRD. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria TX-9780804716697

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 52,67
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,36
In U.S.A.
Destinazione, tempi e costi

3.

Silverman, Milton
Editore: Stanford University Press (2017)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Rilegato Quantità: > 20
Print on Demand
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, 2017. Hardcover. Condizione libro: New. Never used! This item is printed on demand. Codice libro della libreria 0804716692

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 54,81
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 1,68
In U.S.A.
Destinazione, tempi e costi

4.

Milton Silverman, Mia Lydecker, Philip R. Lee
Editore: Stanford University Press, United States (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Rilegato Quantità: 10
Print on Demand
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, United States, 1992. Hardback. Condizione libro: New. Language: English . Brand New Book ***** Print on Demand *****.The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups-the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)-all of which were or still are centers of worldwide, heated controversy. Codice libro della libreria APC9780804716697

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 58,30
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

Milton Silverman, Mia Lydecker, Philip Lee M.D
Editore: Stanford University Press (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Rilegato Quantità: 1
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, 1992. Hardcover. Condizione libro: New. 1. Codice libro della libreria DADAX0804716692

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 50,98
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,57
In U.S.A.
Destinazione, tempi e costi

6.

Milton Silverman
Editore: Stanford University Press (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Quantità: 1
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, 1992. HRD. Condizione libro: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Codice libro della libreria CA-9780804716697

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 49,56
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,24
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

Milton Silverman
Editore: Stanford University Press (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Quantità: > 20
Print on Demand
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, 1992. HRD. Condizione libro: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Codice libro della libreria IP-9780804716697

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 49,56
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,24
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

Milton Silverman, Mia Lydecker, Philip R. Lee
Editore: Stanford University Press, United States (1992)
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Rilegato Quantità: 10
Print on Demand
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Stanford University Press, United States, 1992. Hardback. Condizione libro: New. Language: English . Brand New Book ***** Print on Demand *****. The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups-the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)-all of which were or still are centers of worldwide, heated controversy. Codice libro della libreria APC9780804716697

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 59,81
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

9.

Lee Philip Lydecker Mia Silverman Milton
Editore: Stanford University Press
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Quantità: 3
Da
Majestic Books
(London, ,, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Stanford University Press. Condizione libro: New. pp. 380. Codice libro della libreria 57949189

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 54,53
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,25
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

Milton Silverman, Philip Lee, Mia Lydecker
Editore: Stanford University Press
ISBN 10: 0804716692 ISBN 13: 9780804716697
Nuovi Rilegato Quantità: 5
Da
THE SAINT BOOKSTORE
(Southport, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Stanford University Press. Hardback. Condizione libro: new. BRAND NEW, Bad Medicine: Prescription Drug Industry in the Third World, Milton Silverman, Philip Lee, Mia Lydecker, The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups - the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea) - all of which were or still are centers of worldwide, heated controversy. Codice libro della libreria B9780804716697

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 55,69
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,90
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro